Abstract:Cytoplasmic DNA triggers a danger signal response that has evolved to detect and eradicate infectious organisms. This year's Albert Lasker Basic Medical Research Award to Dr. Zhijian "James" Chen, Professor of Molecular Biology at UT Southwestern Medical Center, recognizes his contributions to determining the mechanism of how DNA is detected and the connection to the downstream signaling cascade that is essential for initiating an immune response. The field had established that DNA triggers proinflammatory IFN responses through the stimulator of IFN genes (STING) pathway ( 1 ) and its phosphorylation of IFN regulatory factor 3 (IRF3) — the transducer of IFN gene transcription ( 2 ). Prior studies showed that the multipass transmembrane STING protein functions as a direct innate immune sensor of bacterial elaborated cyclic diguanylate monophosphate (c-di-GMP) and cyclic diadenylate monophosphate (c-di-AMP) ( 3 ). Several DNA-sensing pattern-recognition receptors, including AIM2-related protein, IFI16, and DDX41, had previously been linked to STING activation. However, it was the Chen laboratory that discovered that the nucleotidyl transferase cyclic GMP-AMP synthase (cGAS) produces a second-messenger cyclic GMP-AMP (cGAMP) that binds to STING as the principal pathway inducing IFN (Figure 1) ( 4 , 5 ). Using a combination of mass spectrometry and protein purification strategies, cGAS was identified, and it was shown to bind to DNA and catalyze the synthesis ,of cGAMP from ATP and GTP. cGAMP binds to STING with high affinity, causing extensive ligand-induced conformational changes ( 6 ). cGAS/STING signaling and therapeutic targeting. ( A ) Activation of the cGAS/STING pathway can be triggered either through the importation of cGAMP or the presence of double-stranded DNA (dsDNA). Activated cyclic GMP-AMP synthase (cGAS) uses ATP and GTP to catalyze the formation of cGAMP that binds to STING localized on the ER membrane. STING then recruits TBK1, which activates/phosphorylates IRF3 and NF-κB, which translocates to the nucleus, thereby inducing the transcriptional activation of proinflammatory interferon responses. ( B ) A variety of therapeutics are being evaluated in clinical trials, such as cyclic dinucleotides or STING agonists that can trigger the activation of cGAS/STING pathway. The STING signal is terminated (denoted by the X) when activated STING in the ER-Golgi compartment binds to LC3 on the autophagy membrane, leading to the degradation of STING and the associated cytoplasmic DNA in the autolysosome. Excess intracellular cGAMP is transported out of the cell and hydrolyzed by ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) to yield AMP and GMP. ENPP1 inhibitors maintain proinflammatory cGAMP concentrations. ERGIC; endoplasmic-reticulum-Golgi intermediate compartment.

Cutting Edge: DNA Sensing Via the STING Adaptor in Myeloid Dendritic Cells Induces Potent Tolerogenic Responses.

DNA sensing via STING regulates autoimmunity and tumor immunity. (IRM5P.648)

STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells

Suppression of systemic autoimmunity by the innate immune adaptor STING

Antagonism of the STING Pathway via Activation of the AIM2 Inflammasome by Intracellular DNA

Engineering DNA Nanoparticles As Immunomodulatory Reagents That Activate Regulatory T Cells

STING Promotes the Growth of Tumors Characterized by Low Antigenicity Via IDO Activation.

A Novel Transcript Isoform of STING That Sequesters Cgamp and Dominantly Inhibits Innate Nucleic Acid Sensing

STING Negatively Regulates Double-Stranded DNA-Activated JAK1-STAT1 Signaling via SHP-1/2 in B Cells.

Cytosolic Sensing of Aberrant DNA: Arming STING on the Endoplasmic Reticulum

STING Is Required in Conventional Dendritic Cells for DNA Vaccine Induction of Type I T Helper Cell- Dependent Antibody Responses

STING an essential trigger of DNA-mediated innate immune signaling. (P1258)

Stimulator of Interferon Genes Agonists attenuate type I diabetes progression in NOD mice.

Transcription-independent regulation of STING activation and innate immune responses by IRF8 in monocytes

Intrinsic STING Switches off Pathogenetic Programs of Th1 Cells to Inhibit Colitis

Abstract A116: Lipid Control of DNA-stimulated Innate Immunity

Stimulator of Interferon Genes in Classical Dendritic Cells Controls Mucosal Th17 Responses to Cyclic Dinucleotides for Host Defenses Against Microbial Infections in Gut.

STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity

Viral DNA Binding to NLRC3, an Inhibitory Nucleic Acid Sensor, Unleashes STING, a Cyclic Dinucleotide Receptor That Activates Type I Interferon.

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

2024 Lasker Award Recipient Zhijian Chen elucidates how DNA stimulates immunity